2013 Talc Study Surfaces Often in Talcum Powder Cancer Lawsuit News
The study conducted by the medical journal Cancer Prevention Research has made talcum powder ovarian cancer lawsuit news by serving as evidence for a large number of cases against Johnson & Johnson that allege the company should have warned consumers of the link between talcum powder and ovarian cancer given the past research available.
Wednesday, Feburary 16, 2016 - A fairly recent study made talcum powder ovarian cancer lawsuit news when the medical journal Cancer Prevention Research published work related to the connection between talcum powder and ovarian cancer. The study, which was published in 2013, has been named in talcum powder lawsuits nationwide as the number of cases has grown over the last few years. Plaintiffs have presented the study as part of their evidence in their arguments alleging that healthcare company Johnson & Johnson (J&J) knew of a significant link between talcum powder and ovarian cancer and chose to intentionally keep that information from consumers in efforts to protect their product.
The study, which will be three-years-old in June, looked at more than 9,000 women who hadn’t used talcum powder and more than 8,000 who had to try to find patterns associated with the correlation between talcum powder and ovarian cancer. The results were also attained with the analysis of eight population-based case-control studies, and used the data garnered from eight separate research papers to further back up their conclusions. The amount of data analysis that was involved in the study has given it a lot of attention in talcum powder cancer lawsuit news, with a large number of plaintiffs claiming it as key evidence against J&J.
The evidence the study offers is that although non-genital use of talcum powder did not show much of a connection, test subjects who used talcum powder genitally did display a significant increase in the risk of ovarian cancer as a result of their habits. A higher rate of clear cell, serous and endometrioid tumors were discovered in the data sets involving test subject that used talcum powder genitally, either daily or occasionally. The overall number reported by the study found that the increased risk of ovarian cancer as a result of using talcum powder to be somewhere between 20 and 30 percent.
The Cancer Prevention Research study is just one of a number publications that have discovered a link between talcum powder and ovarian cancer that have spurred plaintiffs to file suit against J&J for not warning consumers of the dangers of their talcum products given the amount of information available. More than 1,000 lawsuits around the country are currently filed against J&J, including 130 filed against the company in multicounty litigation in its home state of New Jersey. The consolidation into multicounty litigation made talcum powder lawsuit news when it took place in November, and that group of lawsuits as well as hundreds more around the country continue to grow as more research and awareness concerning talcum powder’s connection to ovarian cancer comes to light.
J&J has repeatedly claimed that it has relied on its own group of talcum powder studies that did not find a significant link between the company’s products and ovarian cancer. The company even pointed out that the FDA had yet to take a firm stance on the issue, only saying that the presence of a connection between talcum powder and ovarian cancer was “not conclusive.” However, the weight of research brought by plaintiffs in the talcum powder lawsuits will test the arguments put forth by J&J, and the 2013 Cancer Prevention Research is likely to be a staple in their evidentiary presentations throughout the ensuing legal battle.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.